Effect of Goose Removals on a Suburban Canada Goose Population

Local-nesting or resident Canada geese (Branta canadensis) are coming into conflict with people and human activities in urban-suburban areas throughout North America. Capture and removal of molting geese, followed by translocation or euthanasia, is a simple way to reduce the number of geese in an area, but some critics of lethal goose control methods claim that other geese will quickly fill the void left when geese are removed from a problem area. To better understand the effectiveness of urban-suburban goose removal programs, we captured 591 resident geese (mostly adult birds) in suburban Rockland County, New York, during the summer molt, 2004 and 2005. The birds were transported, marked with neck and leg bands and released in a rural area approximately 320 km to the northwest. Band returns indicated that at least 46% of translocated geese were eventually harvested by hunters, most of those (52%) during the first September hunting season after release, and most (72%) were taken within 50 km of the release site. Neckband observations indicated that \u3c10% of translocated birds returned to Rockland County, and few (\u3c1%) moved to suburban areas near the release site. Annual molting period goose surveys throughout Rockland County from 2004- 2008 indicated that removal of geese from selected sites in Clarkstown resulted in nearly 60% fewer geese town wide for three subsequent years, and other geese did not quickly move in to replace birds that we removed. This study demonstrated that goose removal can be an effective way to reduce local goose populations in some areas for at least three years

A Comparison of Lethal and Non-Lethal Management Approaches to Reduce Damage Associated with Urban Crow Roosts in New York and Virginia

Crow populations have steadily increased in many parts of the country since 1966. Although large winter congregations of crows in urban environments are not a new phenomenon, the number of complaints regarding damage associated with these large (2,000-20,000 individuals) roosts appears to be increasing. In an effort to assist the public in reducing impacts of urban crow roosts, USDA, APHIS, Wildlife Services in Virginia and New York implemented large-scale roost dispersal programs in the winter of 2001-2002. The goal of the programs were to manage local crow populations to minimize associated noise, accumulations of crow fecal droppings on and around residences, strong ammonia odors from fecal droppings, property damage, clean-up costs and threats to human health and safety. Multiple meetings involving the public and key stakeholders were convened where a variety of options and consequences of each option were discussed. Options considered were no action, habitat alteration, cultural methods, roost dispersal, and roost depopulation. Wildlife Services in each state took different approaches to managing crow roosting sites based on state regulations, available tools, scope of the problem, consequences of each management action, effectiveness of methods, and public input. In Virginia, a lethal control program was initiated targeting one roost site (2,000-6 ,000 crows/roost) using the avicide DRC-1339. The goals were to remove a significant percentage of the local crow population and disperse the remaining crows. This project resulted in an estimated 73% reduction in crow numbers at the primary roost site and altered roost dynamics at another roost. The cooperators satisfaction level was an immediate 75% reduction in damage based on a polling of affected property owners. This satisfaction level was based on a reduction in fecal droppings, maintenance costs to clean up fecal droppings, noise, and abundance of crows. In upstate New York, two roost sites (16,000-20,000 crows/roost) were successfully dispersed using a non-lethal hazing program (pyrotechnics, recorded crow distress calls and hand-held lasers). In New York, no avicides were registered at the time of this project and the Cities of Troy and Albany requested that WS try a non-lethal program prior to implementing a lethal control program. The number of crows in the primary roost in the cities of Albany and Troy were reduced by more than 95% over the course of an eight-day program. Significant reduction in crow numbers and damage remained more than eight weeks later. In this paper we will provide a comparison of crow management projects in Virginia and New York and discuss implications of different approaches for managing urban crows

Non-Lethal Management to Reduce Conflicts with Winter Urban Crow Roosts in New York: 2002 - 2007

American crow populations have increased steadily since 1966 in many parts of the U.S. Large winter congregations of crows in urban environments have resulted in an increased number of requests for assistance in managing nocturnal roosts in New York. In 2002, the USDA APHIS Wildlife Services program initiated a large-scale non-lethal winter roost dispersal program in Troy, New York. Since that time, similar programs have been implemented in 4 other cities in New York to manage crow roosts ranging in size from 8,000 - 63,000 individuals. The goals of the programs were to minimize noise, accumulations of crow feces around residences, strong odors associated with droppings, property damage, clean-up costs, and potential threats to human health and safety. The primary management strategy relied on dispersing concentrated crow populations from high-impact high-conflict areas, to low-impact low-conflict areas. An integrated management program using pyrotechnics, amplified recorded crow distress calls, and hand-held lasers was implemented to successfully disperse local crow roosts, reducing populations at the majority of core roost sites each year by more than 98%. In some instances, significant reductions in crow numbers and associated damage persisted \u3e8 weeks after management without additional interventions, although most sites required multiple additional “spot treatments.” High-profile urban wildlife management projects of this type require multiple meetings with key stakeholders and the public and often attract intense media interest, adding complexity to these programs. We provide summary information from 5 cities in New York documenting crow management techniques, intensity of effort, number of interventions required to relocate crow populations, and key lessons learned regarding science-based project documentation, project transparency, communication, and the need for long-term adaptive management strategies to meet project goals

The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review

Background Meningioma clinical trials have assessed interventions including surgery, radiotherapy, and pharmacotherapy. However, agreement does not exist on what, how, and when outcomes of interest should be measured. To do so would allow comparative analysis of similar trials. This systematic review aimed to summarize the outcomes measured and reported in meningioma clinical trials. Methods Systematic literature and trial registry searches were performed to identify published and ongoing intracranial meningioma clinical trials (PubMed, Embase, Medline, CINAHL via EBSCO, and Web of Science, completed January 22, 2022). Reported outcomes were extracted verbatim, along with an associated definition and method of measurement if provided. Verbatim outcomes were deduplicated and the resulting unique outcomes were grouped under standardized outcome terms. These were classified using the taxonomy proposed by the “Core Outcome Measures in Effectiveness Trials” (COMET) initiative. Results Thirty published articles and 18 ongoing studies were included, describing 47 unique clinical trials: Phase 2 n = 33, phase 3 n = 14. Common interventions included: Surgery n = 13, radiotherapy n = 8, and pharmacotherapy n = 20. In total, 659 verbatim outcomes were reported, of which 84 were defined. Following de-duplication, 415 unique verbatim outcomes remained and were grouped into 115 standardized outcome terms. These were classified using the COMET taxonomy into 29 outcome domains and 5 core areas. Conclusions Outcome measurement across meningioma clinical trials is heterogeneous. The standardized outcome terms identified will be prioritized through an eDelphi survey and consensus meeting of key stakeholders (including patients), in order to develop a core outcome set for use in future meningioma clinical trials

The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review

Background The clinical management of patients with incidental intracranial meningioma varies markedly and is often based on clinician choice and observational data. Heterogeneous outcome measurement has likely hampered knowledge progress by preventing comparative analysis of similar cohorts of patients. This systematic review aimed to summarize the outcomes measured and reported in observational studies. Methods A systematic literature search was performed to identify published full texts describing active monitoring of adult cohorts with incidental and untreated intracranial meningioma (PubMed, EMBASE, MEDLINE, and CINAHL via EBSCO, completed January 24, 2022). Reported outcomes were extracted verbatim, along with an associated definition and method of measurement if provided. Verbatim outcomes were de-duplicated and the resulting unique outcomes were grouped under standardized outcome terms. These were classified using the taxonomy proposed by the “Core Outcome Measures in Effectiveness Trials” (COMET) initiative. Results Thirty-three published articles and 1 ongoing study were included describing 32 unique studies: study designs were retrospective n = 27 and prospective n = 5. In total, 268 verbatim outcomes were reported, of which 77 were defined. Following de-duplication, 178 unique verbatim outcomes remained and were grouped into 53 standardized outcome terms. These were classified using the COMET taxonomy into 9 outcome domains and 3 core areas. Conclusions Outcome measurement across observational studies of incidental and untreated intracranial meningioma is heterogeneous. The standardized outcome terms identified will be prioritized through an eDelphi survey and consensus meeting of key stakeholders (including patients), in order to develop a Core Outcome Set for use in future observational studies

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

Abstract Background Variability in standard-of-care classifications precludes accurate predictions of early tumor recurrence for individual patients with meningioma, limiting the appropriate selection of patients who would benefit from adjuvant radiotherapy to delay recurrence. We aimed to develop an individualized prediction model of early recurrence risk combining clinical and molecular factors in meningioma. Methods DNA methylation profiles of clinically annotated tumor samples across multiple institutions were used to develop a methylome model of 5-year recurrence-free survival (RFS). Subsequently, a 5-year meningioma recurrence score was generated using a nomogram that integrated the methylome model with established prognostic clinical factors. Performance of both models was evaluated and compared with standard-of-care models using multiple independent cohorts. Results The methylome-based predictor of 5-year RFS performed favorably compared with a grade-based predictor when tested using the 3 validation cohorts (ΔAUC = 0.10, 95% CI: 0.03–0.018) and was independently associated with RFS after adjusting for histopathologic grade, extent of resection, and burden of copy number alterations (hazard ratio 3.6, 95% CI: 1.8–7.2, P &lt; 0.001). A nomogram combining the methylome predictor with clinical factors demonstrated greater discrimination than a nomogram using clinical factors alone in 2 independent validation cohorts (ΔAUC = 0.25, 95% CI: 0.22–0.27) and resulted in 2 groups with distinct recurrence patterns (hazard ratio 7.7, 95% CI: 5.3–11.1, P &lt; 0.001) with clinical implications. Conclusions The models developed and validated in this study provide important prognostic information not captured by previously established clinical and molecular factors which could be used to individualize decisions regarding postoperative therapeutic interventions, in particular whether to treat patients with adjuvant radiotherapy versus observation alone. </jats:sec

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

Funder: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)Funder: National Center for Research Resources under award number 1 C06 RR12463-01, VA Merit Review Award IBX004121A from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service, the DOD Prostate Cancer Idea Development Award (W81XWH-15-1-0558), the DOD Lung Cancer Investigator-Initiated Translational Research Award (W81XWH-18-1-0440), the DOD Peer Reviewed Cancer Research Program (W81XWH-16-1-0329), the Ohio Third Frontier Technology Validation Fund, the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering and the Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University.Funder: Susan G Komen Foundation (CCR CCR18547966) and a Young Investigator Grant from the Breast Cancer Alliance.Funder: The Canadian Cancer SocietyFunder: Breast Cancer Research Foundation (BCRF), Grant No. 17-194Abstract: Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part of the prognostic workflow in triple-negative (TNBC) and HER2-positive breast cancer, as well as many other solid tumors. This recognition has come about thanks to standardized visual reporting guidelines, which helped to reduce inter-reader variability. Now, there are ripe opportunities to employ computational methods that extract spatio-morphologic predictive features, enabling computer-aided diagnostics. We detail the benefits of computational TILs assessment, the readiness of TILs scoring for computational assessment, and outline considerations for overcoming key barriers to clinical translation in this arena. Specifically, we discuss: 1. ensuring computational workflows closely capture visual guidelines and standards; 2. challenges and thoughts standards for assessment of algorithms including training, preanalytical, analytical, and clinical validation; 3. perspectives on how to realize the potential of machine learning models and to overcome the perceptual and practical limits of visual scoring

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Funder: Breast Cancer Research Foundation (BCRF); doi: https://doi.org/10.13039/100001006Abstract: Stromal tumor-infiltrating lymphocytes (sTILs) are a potential predictive biomarker for immunotherapy response in metastatic triple-negative breast cancer (TNBC). To incorporate sTILs into clinical trials and diagnostics, reliable assessment is essential. In this review, we propose a new concept, namely the implementation of a risk-management framework that enables the use of sTILs as a stratification factor in clinical trials. We present the design of a biomarker risk-mitigation workflow that can be applied to any biomarker incorporation in clinical trials. We demonstrate the implementation of this concept using sTILs as an integral biomarker in a single-center phase II immunotherapy trial for metastatic TNBC (TONIC trial, NCT02499367), using this workflow to mitigate risks of suboptimal inclusion of sTILs in this specific trial. In this review, we demonstrate that a web-based scoring platform can mitigate potential risk factors when including sTILs in clinical trials, and we argue that this framework can be applied for any future biomarker-driven clinical trial setting

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Abstract: Stromal tumor-infiltrating lymphocytes (sTILs) are important prognostic and predictive biomarkers in triple-negative (TNBC) and HER2-positive breast cancer. Incorporating sTILs into clinical practice necessitates reproducible assessment. Previously developed standardized scoring guidelines have been widely embraced by the clinical and research communities. We evaluated sources of variability in sTIL assessment by pathologists in three previous sTIL ring studies. We identify common challenges and evaluate impact of discrepancies on outcome estimates in early TNBC using a newly-developed prognostic tool. Discordant sTIL assessment is driven by heterogeneity in lymphocyte distribution. Additional factors include: technical slide-related issues; scoring outside the tumor boundary; tumors with minimal assessable stroma; including lymphocytes associated with other structures; and including other inflammatory cells. Small variations in sTIL assessment modestly alter risk estimation in early TNBC but have the potential to affect treatment selection if cutpoints are employed. Scoring and averaging multiple areas, as well as use of reference images, improve consistency of sTIL evaluation. Moreover, to assist in avoiding the pitfalls identified in this analysis, we developed an educational resource available at www.tilsinbreastcancer.org/pitfalls

Dead bird effigies: A nightmare for gulls?

Bird control at and around airfields is critical to safe airfield operation. Numerous bird-control products and strategies are available, all of which have limitations because of rapid habituation, ineffectiveness, expense or other factors. There is a need for new methods to manage birds at airports and other locations. In recent years, realistic effigies of dead turkey vultures (Cathartes aura) have proven effective as a species-specific means to disperse roosting vultures. To determine if this concept can be expanded to deter other birds that are a problem at airfields, we conducted trials using prepared ring-billed (Larus delawarensis) and herring (L. argentatus) gulls as effigies at landfills, a nesting colony, and a containment disposal facility (CDF) next to an airport. Results at landfills varied with distance to the active dumping area (active face) and time of year. In winter, gulls loafing away from the active face would stay clear of effigies for up to 4 weeks. When set on or adjacent to the active face, gulls would initially disperse but then return within hours to weeks. Effigies were not effective in nesting colonies. Gull reaction to effigies at a CDF showed initial good response, especially when reinforced with pyrotechnics and lethal control but habituation occurred after 2 months of exposure. We conclude that gull effigies can reduce gull presence in specified areas when used as part of an integrated bird control program. However, effigies alone will not keep gulls away from extensive areas